| 10/08 | Novocure Hosts U.S. Sen. Maggie Hassan at Company's Portsmouth Facility |  |
| 04/08 | INSIDER SELL : Novocure | |
| 28/07 | NovoCure Q2 Loss Widens, Net Revenue Rises | |
| 28/07 | TRANSCRIPT : NovoCure Limited, Q2 2022 Earnings Call, Jul 28, 2022 | |
| 28/07 | NOVOCURE : Q2 Earnings Snapshot | |
| 28/07 | NOVOCURE : Quarterly net revenues of $140.9 million, a 6% increase year-over-year - Form 8.. | |
| 28/07 | Novocure Reports Second Quarter 2022 Financial Results | |
| 28/07 | NOVOCURE LTD Management's Discussion and Analysis of Financial Condition and Results
o.. | |
| 28/07 | NovoCure Limited Reports Earnings Results for the Second Quarter and Six Months Ended J.. | |
| 28/07 | Earnings Flash (NVCR) NOVOCURE Reports Q2 Loss $-0.23 | |
| 28/07 | Earnings Flash (NVCR) NOVOCURE Reports Q2 Revenue $140.9M | |
| 27/07 | Novocure Announces Recipients of 4th Annual AACR-Novocure Grants for Tumor Treating Fie.. | |
| 11/07 | Wedbush Sees Continued Modest Growth in NovoCure's Optune Franchise | |
| 01/07 | Novocure to Report Second Quarter 2022 Financial Results | |
| 24/06 | NOVOCURE LIMITED(NASDAQGS : NVCR) added to Russell 2500 Index | |
| 24/06 | NOVOCURE LIMITED(NASDAQGS : NVCR) added to Russell 2500 Growth Index | |
| 21/06 | NovoCure Enrolls First Patient in Study of Tumor Treating Fields, Keytruda Combination .. | |
| 21/06 | Novocure Enrolls First Patient in KEYNOTE-B36, a Pilot Study of Tumor Treating Fields T.. | |
| 21/06 | Novocure Enrolls First Patient in KEYNOTE-B36, a Pilot Study of Tumor Treating Fields T.. | |
| 10/06 | NOVOCURE LTD : Change in Directors or Principal Officers, Amendments to Articles of Inc. o.. | |
| 03/06 | Novocure Falls 5%, Zai Lab Rises 8%; Companies Report Study Results | |
| 03/06 | Zai Lab, Novocure's Phase 2 Study of Gastric Cancer Combination Therapy Meets Primary E.. | |
| 03/06 | NOVOCURE : Press Release of NovoCure Limited, dated June 3, 2022 - Form 8-K | |
| 03/06 | NOVOCURE LTD : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) | |
| 03/06 | Novocure and Zai Lab Announce EF-31 Phase 2 Pilot Study Evaluating Tumor Treating Field.. | |
| 03/06 | Novocure and Zai Lab Announce EF-31 Phase 2 Pilot Study Evaluating Tumor Treating Field.. | |
| 26/05 | SECTOR UPDATE : Health Care Stocks Propelled Higher Near Thursday Close | |
| 26/05 | SECTOR UPDATE : Health Care Stocks Edging Higher on Thursday | |
| 26/05 | NOVOCURE : Announces Clinical Collaboration with MSD on a Registrational-Intent Study to E.. | |
| 26/05 | NovoCure Teams Up With Merck to Study Tumor Treating Fields Combined With Keytruda to T.. | |
| 26/05 | NOVOCURE LTD : Entry into a Material Definitive Agreement, Other Events, Financial Stateme.. | |
| 26/05 | Novocure Announces Clinical Collaboration with MSD on a Registrational-Intent Study to .. | |
| 26/05 | NovoCure Limited Announces Clinical Collaboration with MSD on a Registrational-Intent S.. | |
| 16/05 | NovoCure's Shares Rise After HC Wainwright Initiates Coverage at Buy | |
| 28/04 | NovoCure's Q1 Net Loss Flat, Revenue Rises | |
| 28/04 | TRANSCRIPT : NovoCure Limited, Q1 2022 Earnings Call, Apr 28, 2022 | |
| 28/04 | NOVOCURE : Q1 Earnings Snapshot | |
| 28/04 | NOVOCURE : Quarterly net revenues of $137.5 million with 80% gross margin - Form 8-K | |
| 28/04 | Earnings Flash (NVCR) NOVOCURE Reports Q1 Loss $-0.04, vs. Street Est of $-0.19 | |
| 28/04 | Earnings Flash (NVCR) NOVOCURE Posts Q1 Revenue $137.5M, vs. Street Est of $134.3M | |
| 28/04 | NOVOCURE LTD Management's Discussion and Analysis of Financial Condition and Results
o.. | |
| 28/04 | Novocure Reports First Quarter 2022 Financial Results | |
| 28/04 | NovoCure Limited Reports Earnings Results for the First Quarter Ended March 31, 2022 | |
| 19/04 | Novocure Hosts Ceremonial Groundbreaking with New Hampshire Governor Chris Sununu | |
| 13/04 | NOVOCURE LTD : Change in Directors or Principal Officers, Financial Statements and Exhibit.. | |
| 13/04 | Novocure Limited Announces Resignation of Sherilyn McCoy from the Board of Directors | |
| 08/04 | Novocure Announces 19 Presentations at American Association for Cancer Research (AACR) .. | |
| 07/04 | NOVOCURE LTD : Other Events, Financial Statements and Exhibits (form 8-K) | |
| 01/04 | Novocure to Report First Quarter 2022 Financial Results | |
| 24/03 | Updated 2-THE-TOP Data Suggest Improvements in Progression-Free Survival, Overall Survi.. | |
| 24/03 | NovoCure Limited Announces Updated 2-THE-TOP Data Suggest Improvements in Progression-F.. | |
| 23/03 | Novocure Announces Favorable Recommendation to Continue the Phase 3 Pivotal INNOVATE-3 .. | |
| 23/03 | NOVOCURE LTD : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) | |
| 23/03 | NovoCure's Phase 3 Study of Tumor Treating Fields Given Independent Recommendation to C.. | |
| 23/03 | NOVOCURE : Announces Favorable Recommendation to Continue the Phase 3 Pivotal INNOVATE-3 S.. | |
| 23/03 | Novocure Announces Favorable Recommendation to Continue the Phase 3 Pivotal INNOVATE-3 .. | |
| 09/03 | INSIDER SELL : NovoCure | |
| 09/03 | INSIDER SELL : NovoCure | |
| 09/03 | INSIDER SELL : Novocure | |
| 28/02 | Novocure Founder Yoram Palti Wins 2022 Israel Prize in Entrepreneurship and Technologic.. | |
| 24/02 | Novocure's General Counsel Resigns After 10 Years of Service | |
| 24/02 | Novocure Announces Resignation of Todd Longsworth as General Counsel | |
| 24/02 | TRANSCRIPT : NovoCure Limited, Q4 2021 Earnings Call, Feb 24, 2022 | |
| 24/02 | NovoCure Swings to Loss, Revenue Declines in Q4; Shares Fall in Premarket | |
| 24/02 | NOVOCURE : Q4 Earnings Snapshot | |
| 24/02 | NOVOCURE : Invested record $201 million in 2021 in research and development initiatives in.. | |
| 24/02 | New Data Finds Tumor Treating Fields Initiates Downstream Anti-Tumor Response | |
| 24/02 | Novocure Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Compa.. | |
| 24/02 | Novocure Announces New Data Finds Tumor Treating Fields Initiates Downstream Anti-Tumor.. | |
| 24/02 | Earnings Flash (NVCR) NOVOCURE Posts Q4 Revenue $133.2M | |
| 24/02 | NOVOCURE LTD MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
O.. | |
| 24/02 | NovoCure Limited Reports Earnings Results for the Fourth Quarter Ended December 31, 202.. | |
| 24/02 | NovoCure Limited Reports Earnings Results for the Full Year Ended December 31, 2021 | |
| 08/02 | NovoCure Shares Rise After Loop Capital Initiates Coverage With Buy Rating, $200 Price .. | |
| 02/02 | NovoCure Shares Higher After Oppenheimer Upgrade to Outperform | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Reporte
